Skip to content

A randomized controlled trial for comparing the hemostatic effects of fluid gelatin and gelatin sponge in posterior cervical decompression surgery

A randomized controlled trial for comparing the hemostatic effects of fluid gelatin and gelatin sponge in posterior cervical decompression surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037849
Enrollment
Unknown
Registered
2020-09-03
Start date
2020-09-07
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylosis

Interventions

2:Gelatin sponge
1:Absorbable fluid gelatin

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
27 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 27-65 years old; 2. Patients with multi-level cervical spinal stenosis, multi-level cervical disc herniation or ossification of posterior longitudinal ligament with complete history, physical examination and imaging examination; 3. Patients with clear indication of operation.

Exclusion criteria

Exclusion criteria: 1. Patients with severe medical complications such as anemia, renal failure and cardiovascular disease; 2. Patients with abnormal coagulation function before operation; 3. Patients who have recently taken antiplatelet or anticoagulant drugs or aspirin for less than 1 week; 4. Patients with a history of thrombosis or high risk of thrombosis, including atrial fibrillation, pacemaker and stent implantation; 5. Patients with uncontrolled systemic infection such as pulmonary infection and urinary tract infection before operation; 6. Patients with abnormal immune function or immune related diseases before operation; 7. Patients with abnormal preoperative inflammatory indexes (CRP > 20 mg / L); 8. Identify the patients who are allergic to gelatin sponge or fluid gelatin or have contraindications; 9. Patients with history of spasm or epilepsy; 10. Patients who are participating in other research projects.

Design outcomes

Primary

MeasureTime frame
Bleeding volume;Drainage;Blood index;

Secondary

MeasureTime frame
Intraoperative bleeding time;Blood transfusion volume/rate;Days of drainage fluid;Operation time;Hospital stay;Complications;Patient satisfaction score;Patient quality of life score (VAS, JOA, NDI);

Countries

China

Contacts

Public ContactHao Liu

West China Hospital, Sichuan University

liuhaohxyy@163.com+86 18980601369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026